(Q53900090)
Statements
Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study. (English)
Laham RJ
Chronos NA
Pike M
Leimbach ME
Udelson JE
Pearlman JD
Pettigrew RI
Whitehouse MJ
Yoshizawa C
1 December 2000
36
7
2132-2139